Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 37 (RPL21P37)

Target: RPL21P37
Molecular classification: Other (Pseudogene)

Overview

RPL21P37 (ribosomal protein L21 pseudogene 37) is a processed pseudogene related to the ribosomal protein L21 gene. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional; they do not encode proteins. The human genome contains many processed pseudogenes for ribosomal proteins, including L21. These exist as remnants of gene duplication or retrotransposition events and do not contribute to ribosomal function, have no direct biological activity, and are not considered therapeutic targets[2][1][3].

Other names: RPL21_11_229RPL21P37

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 37 (RPL21P37).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 37 (RPL21P37).

Explore the full profile